498 filings
Page 6 of 25
4
Christopher Molineaux
9 Nov 21
Calithera Biosciences / Christopher Molineaux ownership change
7:37pm
4
Eric Sjogren
9 Nov 21
Calithera Biosciences / Eric Sjogren ownership change
7:35pm
4
Wong Stephanie
9 Nov 21
Calithera Biosciences / Stephanie Wong ownership change
7:34pm
4
CALA
Calithera Biosciences, Inc.
9 Nov 21
Calithera Biosciences / Sumita Ray ownership change
7:33pm
4
Emil Kuriakose
9 Nov 21
Calithera Biosciences / Emil Kuriakose ownership change
7:32pm
4
Francesco Parlati
9 Nov 21
Calithera Biosciences / Francesco Parlati ownership change
7:28pm
3
Emil Kuriakose
9 Nov 21
Calithera Biosciences / Emil Kuriakose ownership change
7:25pm
10-Q
2021 Q3
CALA
Calithera Biosciences, Inc.
Quarterly report
9 Nov 21
4:46pm
8-K
CALA
Calithera Biosciences, Inc.
9 Nov 21
Calithera Biosciences Reports Third Quarter 2021 Financial Results and Recent Highlights
4:31pm
8-K
CALA
Calithera Biosciences, Inc.
5 Nov 21
Calithera Biosciences Announces Decision to Discontinue KEAPSAKE Clinical Trial
6:10am
4
Eric Sjogren
29 Oct 21
Calithera Biosciences / Eric Sjogren ownership change
6:55pm
4
Keith Orford
29 Oct 21
Calithera Biosciences / Keith Orford ownership change
6:51pm
4
Christopher Molineaux
29 Oct 21
Calithera Biosciences / Christopher Molineaux ownership change
6:51pm
4
Wong Stephanie
29 Oct 21
Calithera Biosciences / Stephanie Wong ownership change
6:50pm
4
Sumita Ray
29 Oct 21
Calithera Biosciences / Sumita Ray ownership change
6:48pm
4
Francesco Parlati
29 Oct 21
Calithera Biosciences / Francesco Parlati ownership change
6:47pm
8-K
CALA
Calithera Biosciences, Inc.
19 Oct 21
Calithera Expands Oncology Pipeline with Acquisition of Two Clinical-Stage Assets from Takeda Pharmaceuticals
6:08am
8-K
CALA
Calithera Biosciences, Inc.
16 Sep 21
Other Events
4:01pm
10-Q
2021 Q2
CALA
Calithera Biosciences, Inc.
Quarterly report
5 Aug 21
4:41pm
8-K
CALA
Calithera Biosciences, Inc.
5 Aug 21
Calithera Biosciences Reports Second Quarter 2021 Financial Results and Recent Highlights
4:35pm